Inflammatory bowel disease evaluated by low-field magnetic resonance imaging: Comparison with endoscopy, 99mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 3, 2002, Pages 307-316

  Madsen, Søren Martin ^a   Thomsen, H S ^a   Munkholm, P ^a   Davidsen, B ^a   Dorph, S ^a   Nielsen, S Levin ^a   Schlichting, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Crohn disease; Inflammatory bowel disease; Magnetic resonance imaging; Ulcerative colitis

Indexed keywords

GADODIAMIDE; GLUCOCORTICOID; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PREDNISOLONE; RECOMBINANT GLUCAGON;

ADULT; AGED; ARTICLE; BARIUM ENEMA; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CORRELATION FUNCTION; CORTICOSTEROID THERAPY; CROHN DISEASE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; ENDOSCOPY; ENTERITIS; FEMALE; HUMAN; INTESTINE RADIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; SCINTIGRAPHY; ULCERATIVE COLITIS;

ADULT; AGED; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036186125     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202317284219     Document Type: Article

References (38)

1. CT features of ulcerative colitis and Crohn's disease
2. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium ppm-hexamethyl propylene amine oxine as leukocyte label
3. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: Diagnostic and clinical relevance
4. Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings
5. Optimization of technetium-99m-HMPAO leucocyte scintigraphy in evaluation of active inflammatory bowel disease
6. Incidence and prevalence of ulcerative colitis in Copenhagen County from 1962 to 1987
7. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: A sixfold increase in incidence
8. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone
9. Predictability of the postoperative course of Crohn's disease
10. Survey of the use of colonoscopy in inflammatory bowel disease
11. Histologic and colonoscopic assessment of disease extension in ulcerative colitis
12. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease
13. Leucocyte scintigraphy to localize inflammatory activity in ulcerative colitis and Crohn's disease
14. Do technetium-99m hexamethylpropylene amine oxime-labelled leucocytes truly reflect the mucosal inflammation in patients with ulcerative colitis?
15. Magnetic resonance imaging in inflammatory bowel disease
16. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease
17. Magnetic resonance imaging in inflammatory bowel disease: Assessment of localisation and inflammatory activity
18. Bowel disease: Prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences
19. Active Crohn's disease and ulcerative colitis evaluated by low-field magnetic resonance imaging
20. Small-bowel disease: Comparison of MR enteroclysis images with conventional enteroclysis and surgical findings
21. Magnetic resonance imaging with ferumoxil, a negative superparamagnetic oral contrast agent, in the evaluation of ulcerative colitis
22. Crohn's disease evaluation: Comparison of contrast-enhanced MR imaging and single-phase helical CT scanning
23. Diagnostic imaging in Crohn's disease: Comparison of magnetic resonance imaging and conventional methods
24. MRI in the diagnosis of small bowel disease: Use of positive and negative oral contrast media in combination with enteroclysis
25. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation
26. Evaluation of Crohn disease activity with magnetic resonance imaging
27. Magnetic resonance imaging in Crohn's disease. Early recognition of treatment response and relapse: A case report
28. Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging
29. Development of a Crohn's disease activity index. National cooperative Crohn's disease study
30. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)
31. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis
32. Evaluation of a new leucocyte labelling procedure with 99mTc-HMPAO
33. From the Danish Breast Cancer Cooperative Group (DBCG). Clinical trials
34. Selection factors in clinical trials: Results from the community clinical oncology program physicians patient log
35. Ethical aspects of clinical trials: The attitudes of participants in two non-cancer trials
36. Attitudes towards clinical research of participants and non-participants
37. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: Correlation with clinical evaluation, Crohn's disease activity index, and alpha(1)-antitrypsin clearance in feces